Literature DB >> 25061715

Influence of evidence type and narrative type on HPV risk perception and intention to obtain the HPV vaccine.

Xiaoli Nan1, Michael F Dahlstrom, Adam Richards, Sarani Rangarajan.   

Abstract

This research examines the influence of evidence type (statistical, narrative, or hybrid) and narrative type (first-person or third-person) on risk perception about human papillomavirus (HPV) and behavioral intention to get the HPV vaccine. In total, 174 college students who had not received the HPV vaccine participated in a controlled experiment. Results show that the hybrid message containing both statistical and narrative descriptions of HPV resulted in greater perceived risk of getting HPV than either of the messages containing just one type of evidence--statistical or narrative. Moreover, the first-person narrative message led to greater risk perception about HPV than the third-person narrative message. Both evidence type and narrative type had an indirect effect on intention to get the HPV vaccine free of cost through HPV risk perception. Implications of the findings for vaccine risk communication are discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25061715     DOI: 10.1080/10410236.2014.888629

Source DB:  PubMed          Journal:  Health Commun        ISSN: 1041-0236


  16 in total

1.  Using narratives and storytelling to communicate science with nonexpert audiences.

Authors:  Michael F Dahlstrom
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-15       Impact factor: 11.205

2.  Human papillomavirus risk perceptions and relationship status: a barrier to HPV vaccination?

Authors:  Erika L Thompson; Cheryl A Vamos; Rumour Piepenbrink; Mika Kadono; Coralia Vázquez-Otero; Sarah Matthes; Ellen M Daley
Journal:  J Behav Med       Date:  2019-03-16

3.  African American Parents' Perceived Vaccine Efficacy Moderates the Effect of Message Framing on Psychological Reactance to HPV Vaccine Advocacy.

Authors:  Adam S Richards; Yan Qin; Kelly Daily; Xiaoli Nan
Journal:  J Health Commun       Date:  2021-08-24

4.  Reviews on common objectives and evaluation indicators for risk communication activities from 2011 to 2017.

Authors:  Akiko Sato; Kaori Honda; Kyoko Ono; Reiko Kanda; Takehiko I Hayashi; Yoshihito Takeda; Yoshitake Takebayashi; Tomoyuki Kobayashi; Michio Murakami
Journal:  PeerJ       Date:  2020-08-25       Impact factor: 2.984

5.  The association between maternal human papillomavirus (HPV) experiences and HPV vaccination of their children.

Authors:  Erika Biederman; Kelly Donahue; Lynne Sturm; Victoria Champion; Gregory Zimet
Journal:  Hum Vaccin Immunother       Date:  2020-10-07       Impact factor: 3.452

6.  Message Framing, Perceived Susceptibility, and Intentions to Vaccinate Children Against HPV Among African American Parents.

Authors:  Xiaoli Nan; Kelly Madden; Adam Richards; Cheryl Holt; Min Qi Wang; Kate Tracy
Journal:  Health Commun       Date:  2015-12-08

7.  Invited Commentary: Moving From Evidence to Impact for Human Papillomavirus Vaccination-The Critical Role of Translation and Communication in Epidemiology.

Authors:  Anne F Rositch; Melinda Krakow
Journal:  Am J Epidemiol       Date:  2018-06-01       Impact factor: 4.897

8.  Testimonials and Informational Videos on Branded Prescription Drug Websites: Experimental Study to Assess Influence on Consumer Knowledge and Perceptions.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Jennifer Gard Read; Jacqueline B Amoozegar; Kathryn J Aikin; Douglas J Rupert
Journal:  J Med Internet Res       Date:  2018-01-23       Impact factor: 5.428

9.  Persuasiveness of Statistics and Patients' and Mothers' Narratives in Human Papillomavirus Vaccine Recommendation Messages: A Randomized Controlled Study in Japan.

Authors:  Tsuyoshi Okuhara; Hirono Ishikawa; Masafumi Okada; Mio Kato; Takahiro Kiuchi
Journal:  Front Public Health       Date:  2018-04-12

10.  Amount of Narratives Used on Japanese Pro- and Anti-HPV Vaccination Websites: A Content Analysis

Authors:  Tsuyoshi Okuhara; Hirono Ishikawa; Masafumi Okada; Mio Kato; Takahiro Kiuchi
Journal:  Asian Pac J Cancer Prev       Date:  2018-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.